Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Carl Zeiss Meditec AG    AFX   DE0005313704

CARL ZEISS MEDITEC AG

(AFX)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Carl Zeiss Meditec AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/04/2019 | 03:05am EDT

DGAP Preliminary announcement financial reports: Carl Zeiss Meditec AG / Preliminary announcement on the disclosure of financial statements
Carl Zeiss Meditec AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

04.02.2019 / 09:00
Preliminary announcement of the publication of quarterly reports and quarterly/interim statements transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Carl Zeiss Meditec AG hereby announces that the following financial reports shall be disclosed :

Report: Quarterly/ Interim statement within the 1st half-year Date of disclosure / German: February 11, 2019 Date of disclosure / English: February 11, 2019 German: https://applications.zeiss.com/C1257A290053AE30/0/DE1721ECDE1C38C7C12583900044BB55/$FILE/q1-quartalsmitteilung.pdf English: https://applications.zeiss.com/C1257A290053AE30/0/0876ADE6C64C26EFC125839000459166/$FILE/q1-quarterly-statement.pdf



04.02.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Carl Zeiss Meditec AG
Göschwitzer Str. 51-52
07745 Jena
Germany
Internet: www.zeiss.de/meditec-ag/ir

 
End of News DGAP News Service

771495  04.02.2019 

fncls.ssp?fn=show_t_gif&application_id=771495&application_name=news&site_id=zonebourse

© EQS 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CARL ZEISS MEDITEC AG
08/12CARL ZEISS MEDITEC : continues strong growth trend after nine months of 2018/19
AQ
08/09EUROPE : Italy leads European shares lower on political uncertainty
RE
08/09GLOBAL MARKETS LIVE : Bayer, Huawei, Airbus, Occidental Petroleum…
08/09CARL ZEISS MEDITEC : continues strong growth trend after nine months of 2018/19
EQ
08/02CARL ZEISS MEDITEC AG : Preliminary announcement of the publication of quarterly..
EQ
07/16INFORMATION PURSUANT : Carl Zeiss Meditec is aiming for the upper end of its rev..
PU
07/15CARL ZEISS MEDITEC : is aiming for the upper end of its revenue forecast for the..
EQ
06/19EUROPE : European stocks tread water, all eyes on Fed
RE
06/18A pivotal month of June
06/04A war on all fronts
More news
Financials (EUR)
Sales 2019 1 428 M
EBIT 2019 264 M
Net income 2019 168 M
Finance 2019 663 M
Yield 2019 0,67%
P/E ratio 2019 52,6x
P/E ratio 2020 45,0x
EV / Sales2019 5,76x
EV / Sales2020 5,23x
Capitalization 8 886 M
Chart CARL ZEISS MEDITEC AG
Duration : Period :
Carl Zeiss Meditec AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARL ZEISS MEDITEC AG
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 10
Average target price 92,38  €
Last Close Price 99,55  €
Spread / Highest target 0,45%
Spread / Average Target -7,20%
Spread / Lowest Target -17,6%
EPS Revisions
Managers
NameTitle
Ludwin Monz President & Chief Executive Officer
Michael Kaschke Chairman-Supervisory Board
Justus Felix Wehmer Chief Financial Officer
Markus Guthoff Member-Supervisory Board
Cornelia Grandy Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
CARL ZEISS MEDITEC AG45.46%9 796
THERMO FISHER SCIENTIFIC31.97%119 202
DANAHER CORPORATION36.39%101 163
INTUITIVE SURGICAL9.34%60 303
BOSTON SCIENTIFIC CORPORATION18.68%58 240
EDWARDS LIFESCIENCES CORPORATION40.43%45 649